Specify a stock or a cryptocurrency in the search bar to get a summary
NIOX Group PLC
NIOXNIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. Address: Hayakawa Building, Oxford, United Kingdom, OX4 4GB
Analytics
WallStreet Target Price
6 180.61 GBXP/E ratio
31.6Dividend Yield
1.55 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NIOX
Dividend Analytics NIOX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NIOX
Stock Valuation NIOX
Financials NIOX
Results | 2019 | Dynamics |